You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 2 No. 2, Apr-Jun 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Facial Plastic Surgery
 •Biomaterials and Implants
 •Alert me on articles by topic

Evaluation of Acellular Dermal Graft in Sheet (AlloDerm) and Injectable (Micronized AlloDerm) Forms for Soft Tissue Augmentation

Clinical Observations and Histological Analysis

Anthony P. Sclafani, MD; Thomas Romo III, MD; Andrew A. Jacono, MD; Steven McCormick, MD; Rubina Cocker, MD; Andrew Parker, MD

Arch Facial Plast Surg. 2000;2:130-136.

Objectives  To evaluate the histological and clinical properties of (1) subdermally implanted acellular dermal graft (AlloDerm) sheets vs intradermal bovine collagen and (2) subdermally or intradermally injected micronized AlloDerm vs type I bovine collagen cross-linked with glutaraldehyde (Zyplast).

Patients  Twenty-five adult patients testing nonallergic to bovine collagen.

Methods  (1) Stacked disks of AlloDerm were implanted subdermally behind one ear, and bovine collagen was injected intradermally behind the other. The soft tissue augmentation caused by the implants was measured by digital photography at 1, 4, and 12 weeks, and biopsy specimens of each implant type were examined at 3 months after implantation. (2) Micronized AlloDerm was injected intradermally and subdermally in 2 different locations behind one ear, and bovine collagen was injected in the same manner behind the other. The soft tissue augmentation caused by the implants was measured by digital photography at the time of implantation and at 1 and 4 weeks after implantation. All implants were examined 1 month after implantation.

Results  All patients tolerated both implants well. (1) AlloDerm implants retained a higher percentage of the original implant volume than Zyplast at 1 and 3 months after implantation. Histologically, AlloDerm implants were extensively invaded by host fibroblasts without any foreign body reaction. (2) Intradermally injected micronized AlloDerm implants retained a higher percentage of the original implant volume at 1 month after implantation than intradermal Zyplast. Histologically, micronized AlloDerm implants were extensively invaded by host fibroblasts without any foreign body reaction. No significant differences were noted between subdermally injected micronized AlloDerm and Zyplast.

Conclusions  The macroscopic and microscopic behavior of subdermally implanted AlloDerm sheets and subdermally and intradermally injected micronized AlloDerm was compared with intradermally injected Zyplast. AlloDerm sheet volume persisted to a significantly (P<.001) greater degree than bovine collagen during the first 3 months after placement. Clinically, intradermally injected micronized AlloDerm volume persisted to a significantly (P=.01, .04, and .01, respectively) greater degree than intradermal Zyplast or subdermal micronized AlloDerm or Zyplast. Histologically, micronized AlloDerm and AlloDerm are well tolerated at 1 and 3 months, respectively. Host tissue incorporation with fibroblast ingrowth and collagen deposition is seen in both materials. AlloDerm and micronized AlloDerm hold promise for use in facial soft tissue augmentation.


From the Division of Facial Plastic Surgery (Drs Sclafani and Romo) and the Departments of Otolaryngology–Head & Neck Surgery (Drs Sclafani, Romo, Jacono, and Parker) and Pathology (Drs McCormick and Cocker), The New York Eye and Ear Infirmary, New York; and the Department of Otolaryngology–Head & Neck Surgery, New York Medical College, Valhalla (Drs Sclafani and Romo).


RELATED ARTICLE

Archives of Facial Plastic Surgery Reader's Choice: Continuing Medical Education
Arch Facial Plast Surg. 2000;2(2):155-156.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Endoscopic Microflap Technique for the Management of Superficially Displaced Acellular Human Cadaveric Dermis During Injection Laryngoplasty
Buckmire
Arch Otolaryngol Head Neck Surg 2009;135:205-208.
FULL TEXT  

Surgical Treatment for Empty Nose Syndrome
Houser
Arch Otolaryngol Head Neck Surg 2007;133:858-863.
ABSTRACT | FULL TEXT  

Promotion of acellular dermal matrix resolution in vitro by matrix metalloproteinase-2.
Lindman et al.
Arch Facial Plast Surg 2006;8:208-212.
ABSTRACT | FULL TEXT  

Rhinoplasty and the Nasal SMAS Augmentation Graft: Advantages and Indications
Davis and Wayne
Arch Facial Plast Surg 2004;6:124-132.
ABSTRACT | FULL TEXT  

Rejuvenation of the Aging Lip With an Injectable Acellular Dermal Graft (Cymetra)
Sclafani et al.
Arch Facial Plast Surg 2002;4:252-257.
ABSTRACT | FULL TEXT  

Evaluation of Acellular Dermal Graft (AlloDerm) Sheet for Soft Tissue Augmentation: A 1-Year Follow-up of Clinical Observations and Histological Findings
Sclafani et al.
Arch Facial Plast Surg 2001;3:101-103.
ABSTRACT | FULL TEXT  

Acellular Dermal Graft for Soft Tissue Augmentation
Journal Watch Dermatology 2000;2000:5-5.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.